Dermira Investors

18 investors on Angel Roster list Dermira in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Dermira can appear together.

Investors listed
18
With verified email
56%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 18 Dermira investors

The most complete profiles first. Showing 18 of 18.

  • Jonathan Waldstreicher, MDVerified

    Venture Capital, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: Dermira, Braeburn, Gloucester Pharmaceuticals, QualDerm Partners and 22 more

    Verified email available

  • Sunny ReddyVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Wende HuttonVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: OncoResponse, Apieron, Hyalex Orthopaedics, Calibra Medical and 12 more

    Verified email available

  • Aftab KheraniVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Andrew SchiffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more

    Verified email available

  • David BeierVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Verified email available

  • Eric AguiarVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Josh BilenkerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Robert WenzelVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Dayton Misfeldt

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Fred Craves

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Matt Kronmiller

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Scott Braunstein

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

  • Seth Harrison

    Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Dermira, Braeburn, Gloucester Pharmaceuticals, QualDerm Partners and 21 more

    Contact details available

  • Sophie Phillips

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

  • carl goldfischer

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Jake NunnVerified

    Venture Capital, Angel/Individual, Investor · United States

    Series BE-commerceWomen FoundedAppsArtificial Intelligence (AI)

    Portfolio: Dermira, TriVascular, Hyperion Therapeutics, Transcept Pharmaceuticals

    Verified email available

  • Dylan Bird

    Angel/Individual · United States

    Health CareEnterprise SoftwareMobileClean Technology

    Portfolio: Dermira, sunesis pharmaceutical, GenturaDx, Epizyme and 4 more

    Contact details available

Frequently asked questions

How many Dermira investors are on Angel Roster?

Angel Roster lists 18 Dermira investors. 10 of them (56%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (16), Private Equity Firms (9) and Angel Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Dermira investors invest in?

Among those that list a stage, the most common are Series B (2), Seed (2) and Series A (1).

Where are Dermira investors based?

Most are based in the United States (18).

Which companies have Dermira investors backed?

The most-backed portfolio companies among them are VYNE Therapeutics (13), TRIA Beauty (13), NextWave Pharmaceuticals (13), Prolacta Bioscience (8) and T2 Biosystems (8).

How do I contact Dermira investors?

Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.